CVE-2025-27721VulnerabilityPublished 21 Aug 2025

CVE-2025-27721: INFINITT PACS System Manager · CWE-497

Affects INFINITT PACS System ManagerSource CVE Database V5

Not known to be exploited · CVSS 7.5 High.

Data as of 25 Oct 2026, 19:02 UTC

CVSS 3.1 base score

7.5High

How severe the flaw is on the 0–10 CVSS scale.

EPSS: 0.3% chance of exploitation in 30 days – higher than 26% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Attack Vector: Network
Attack Complexity: Low
Privileges Required: None
User Interaction: None
Scope: Unchanged
Confidentiality: High
Integrity: None
Availability: None

Bold values are the worst case: easiest to exploit or largest impact.

Attack Vector: Network: The vulnerable component is bound to the network stack and the set of possible attackers extends beyond the other options listed, up to and including the entire Internet. Such a vulnerability is often termed 'remotely exploitable' and can be thought of as an attack being exploitable at the protocol level one or more network hops away (e.g., across one or more routers).
Attack Complexity: Low: Specialized access conditions or extenuating circumstances do not exist. An attacker can expect repeatable success against the vulnerable component.
Privileges Required: None: The attacker is unauthorized prior to attack, and therefore does not require any access to settings or files to carry out an attack.
User Interaction: None: The vulnerable system can be exploited without any interaction from any user.
Scope: Unchanged: An exploited vulnerability can only affect resources managed by the same security authority. In this case, the vulnerable component and the impacted component are either the same, or both are managed by the same security authority.
Confidentiality: High: There is total loss of confidentiality, resulting in all resources within the impacted component being divulged to the attacker. Alternatively, access to only some restricted information is obtained, but the disclosed information presents a direct, serious impact.
Integrity: None: There is no loss of integrity within the impacted component.
Availability: None: There is no impact to availability within the impacted component.

Definitions: FIRST CVSS v3.1 specification.

Exploitation evidence

Disclosed: evidence found.
CVE published 21 Aug 2025
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2026-10-25.

Disclosed: The CVE record is public on cve.org. Its publication is t = 0.
Detectable: A public nuclei template can find exposed instances, for defenders and attackers alike.
Weaponised: Public exploit code exists in Metasploit or Exploit-DB, or CISA SSVC reports a public proof of concept.
Exploited in the wild: CISA KEV lists it, CISA SSVC rates exploitation active, or a source reports attacks.
Observed by OffSeq Mirage: OffSeq Mirage honeypot sensors recorded attack traffic for this CVE, or found exposed hosts without attack traffic.

Moments are spaced evenly, not to scale; a dashed line marks a gap of six months or more. Deltas count from t = 0. Sources that give only a date (CISA KEV, Exploit-DB, or a time of exactly 00:00Z) read “same day” rather than hours. Metasploit modules carry the flaw’s disclosure date, not their release date, and nuclei templates carry no date, so both appear above but not on the timeline.

What to do

Affected software

Product	Affected	Fixed in
INFINITT Healthcare INFINITT PACS System Manager	Affected =0	Fixed in–

AI-suggested

Given the absence of an official patch at this time, European healthcare organizations should implement several specific mitigations: 1) Restrict network access to the INFINITT PACS System Manager by implementing strict firewall rules and network segmentation to limit exposure to trusted internal networks only. 2) Employ strong access control measures such as multi-factor authentication (MFA) on all management interfaces to add an additional layer of verification beyond the vulnerable authentication mechanism. 3) Monitor and audit access logs for unusual or unauthorized access attempts to detect potential exploitation early. 4) Use intrusion detection/prevention systems (IDS/IPS) tuned to detect anomalous traffic patterns targeting PACS management interfaces. 5) Engage with INFINITT Healthcare to obtain updates on patch availability and apply security updates promptly once released. 6) Conduct regular security assessments and penetration testing focused on PACS infrastructure to identify and remediate other potential weaknesses. 7) Educate IT and security staff on the risks associated with this vulnerability and the importance of rapid incident response. These targeted actions go beyond generic advice by focusing on network-level controls, enhanced authentication, and proactive monitoring tailored to the specific characteristics of this vulnerability.

Description

Unauthorized users can access INFINITT PACS System Manager without proper authorization, which could lead to unauthorized access to system resources.

Impact

For European organizations, particularly healthcare providers and medical imaging centers using INFINITT PACS System Manager, this vulnerability poses a significant risk to patient data confidentiality. Unauthorized access could lead to exposure of sensitive medical images and associated patient information, potentially violating GDPR and other data protection laws, resulting in legal penalties and reputational damage. The breach of confidentiality could also undermine patient trust and disrupt clinical workflows if sensitive data is leaked or misused. Although the vulnerability does not affect system integrity or availability, the confidentiality breach alone is critical in the healthcare context. Additionally, healthcare institutions are often targeted by cybercriminals and nation-state actors due to the value of medical data, making this vulnerability a potential vector for espionage or ransomware attacks. The lack of required privileges and user interaction lowers the barrier for attackers, increasing the likelihood of exploitation. European healthcare organizations must therefore prioritize addressing this vulnerability to maintain compliance and protect patient privacy.

CWE-497Exposure of Sensitive System Information to an Unauthorized Control Sphere (opens in a new tab)
Base weaknessOWASP Top 10 A01:2025: Broken Access Control (opens in a new tab)
The product does not properly prevent sensitive system-level information from being accessed by unauthorized actors who do not have the same level of access to the underlying system as the product does.
Architecture and Design · Implementation
Production applications should never use methods that generate internal details such as stack traces and error messages unless that information is directly committed to a log that is not viewable by the end user.
OWASP Cheat Sheets
Error Handling (opens in a new tab)
Authorization (opens in a new tab)
OWASP ASVS 4.0.3
V14.3.2 (opens in a new tab)
V8.3.4 (opens in a new tab)
V14.3.3 (opens in a new tab)
Attack patterns
Web Application Fingerprinting (opens in a new tab)
System Location Discovery (opens in a new tab)
From MITRE CWE, MITRE CAPEC and OWASP (Top 10, OpenCRE).

References

cisa.gov/news-events/ics-medical-advisories/icsma-25-100-01 (opens in a new tab)

Community reviews

Loading reviews…

Exploitation evidence

What to do

Affected software

Description

AI analysisMachine-generated, updated 29 Aug 2025, 01:10 UTC

WeaknessesCWE-497

Technical details

References

Community reviews

Related threats